Roivant Sciences (ROIV) Non Operating Investment Income (2020 - 2025)
Roivant Sciences' Non Operating Investment Income history spans 6 years, with the latest figure at $21.6 million for Q4 2025.
- For Q4 2025, Non Operating Investment Income rose 201.3% year-over-year to $21.6 million; the TTM value through Dec 2025 reached $109.7 million, up 244.61%, while the annual FY2025 figure was $55.2 million, 215.04% up from the prior year.
- Non Operating Investment Income reached $21.6 million in Q4 2025 per ROIV's latest filing, down from $128.5 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $128.5 million in Q3 2025 to a low of -$54.7 million in Q3 2022.
- Average Non Operating Investment Income over 5 years is $674500.0, with a median of -$9.5 million recorded in 2021.
- Peak YoY movement for Non Operating Investment Income: skyrocketed 301.3% in 2024, then plummeted 225.61% in 2025.
- A 5-year view of Non Operating Investment Income shows it stood at -$38.0 million in 2021, then surged by 168.22% to $25.9 million in 2022, then crashed by 140.34% to -$10.5 million in 2023, then crashed by 103.63% to -$21.3 million in 2024, then surged by 201.3% to $21.6 million in 2025.
- Per Business Quant, the three most recent readings for ROIV's Non Operating Investment Income are $21.6 million (Q4 2025), $128.5 million (Q3 2025), and -$19.1 million (Q2 2025).